Bio Protocol vs RedStone — how do they compare? Bio Protocol trades at Rp441.1 (market cap Rp998,02M, Rp177,99M 24h volume), while RedStone trades at Rp1,525 (market cap Rp730,02M, Rp29,09M 24h volume). The key difference: Bio Protocol is the larger of the two by market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 479M / 1B RED (48%) for RedStone. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and RedStone for 14 Days on average.
| BIO | RED | |
|---|---|---|
Market Cap | Rp998,02M | Rp730,02M |
Volume (24h) | Rp177,99M | Rp29,09M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 479M / 1B RED (48%) |
Typical Hold Time | 18 Days | 14 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
RedStone (RED) is trading at Rp1,502 with a bearish technical signal driven by moving averages, though oscillators are neutral. The token has a market cap of Rp721.82 million with 48% of its 1 million max supply in circulation. Current price is near support at Rp1,510, with resistance at Rp1,580. No major protocol updates or ecosystem news were identified recently.
Overall outlook is cautious due to bearish technicals and limited fundamental catalysts. Key opportunities include potential rebounds from oversold RSI levels, but risks include low liquidity and high volatility. Investors should monitor for any network developments or exchange listings that could impact price action.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →RedStone ($RED) is a decentralized oracle network providing customizable data feeds for DeFi across 70+ blockchains. The RED token supports staking and secures the network while rewarding users.
Read more on RED →